logo
Dr. Drew and Kim Perell Advise a Founder on How to Fix Her Customer Retention Problem

Dr. Drew and Kim Perell Advise a Founder on How to Fix Her Customer Retention Problem

Entrepreneur4 days ago
Get lessons in leadership and setting boundaries from renowned health expert Dr. Drew Pinsky and serial investor Kim Perell on this episode of Entrepreneur Therapy.
Amy Beckley, a Ph.D scientist, faced fertility and miscarriage problems due to low levels of the hormone progesterone. After hitting dead ends with traditional fertility tracking, she created Proov, the first FDA-cleared at-home test that helps women track their fertility hormones using a simple urine strip and mobile app.
The product worked. Maybe a little too well. The typical customer only sticks around for two months.
"We make really effective products that help couples get pregnant," Amy told Dr. Drew Pinsky and Kim Perell on Entrepreneur Therapy, presented by Amazon Business. "Sometimes we get them pregnant too fast, which is great for being a human and for helping people. But not so great for business."
So, how does she build customer retention when the very nature of her product means customers no longer need it? Dr. Drew suggests extending the care journey beyond fertility testing. "You need either a partner or something in there so we can actually take care of these problems you're identifying," he says, referencing the perimenopausal issues her customers face that may require ongoing support through supplements, therapeutics, or other interventions.
Related: 5 Proven Strategies for Retaining Your Best Customers
Perell agrees with the direction, but suggests starting low and going slow. "Don't try to do a lot of partnerships," she says. "Focus on one to two that will have the most value for your business right now."
Amy admits that customer retention isn't her only challenge. She talks about her difficulty creating emotional boundaries as the founder of a small company with a deeply personal mission.
"When I was building the company," she says, "my friends would tell me, 'If this business fails, it's because you're too nice.' I tend to trust people. I genuinely want to help them, and I give people a lot of chances. That can be really detrimental to the business."
Related: The Most Successful Entrepreneurs Know How to Say 'No.' Here's the One Exercise You Need to Learn This Skill.
Dr. Drew relates. "I suffer from the same affliction," he says. "You're someone—like me—who experiences yourself through other people. So if we get a lot of negative stuff back, it really gets in. Perell calls this "the disease to please."
Their solution? Setting emotional boundaries and reframing decisions in a way that centers on the business, rather than the individual. Perell encourages Amy to ask herself, Is this in the best interest of the company? "Sometimes that means making uncomfortable choices," she warns.
But she has a solution for easing the blow when she has to say no. Blame the board. "It takes the pressure off the conversation," she says. "You're not saying no because you don't care; you're saying no because you have a bigger responsibility."
It's advice Amy clearly values. "That was amazing," she says at the end of the session. "They had really, really good advice."
Watch the episode to learn more about Amy's challenges and the advice Dr. Drew and Perrell give to scale her business.
Entrepreneur Therapy is presented by Amazon Business. Smart business buying starts with Amazon Business. Learn more.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Health insurance companies have a problem — people are using their plans more
Health insurance companies have a problem — people are using their plans more

Yahoo

time9 minutes ago

  • Yahoo

Health insurance companies have a problem — people are using their plans more

When medical insurance provider Centene (CNC) opened its books to investors on Friday, the company reported a surprising loss and an uptick in usage. The latter is a broader problem for the industry. In the second quarter, Centene reported an adjusted loss of $79 million and a "health benefits ratio" of 93%. Its benefits ratio, or the amount of its revenue derived from premiums that it pays out for medical care, jumped from 87.6% in the same quarter last year. Moves in that figure can have outsized effects on health insurers' financial performance. "Because of the narrow margins of our health plan business, relatively small changes in our HBR can create significant changes in our financial results," Centene wrote in its Q2 earnings report. And the problem is not isolated to Centene. Elevance Health (ELV), which offers plans including Blue Cross and Blue Shield, reported a similar jump in its "benefit expense ratio" to 88.9% in the second quarter, up from 86.3% in the same quarter last year. Both Centene and Elevance attributed the jump especially to their government-subsidized offerings under the Medicaid and Medicare programs. Molina Healthcare (MOH), which reported Q2 earnings earlier this month, reported a similar outlook, attributing its lowered earnings guidance to the same trend facing other medical insurers. "The short-term earnings pressure we are experiencing results from what we believe to be a temporary dislocation between premium rates and medical cost trend which has recently accelerated,' Molina CEO Joseph Zubretsky said in a statement. Elevance stock dropped by roughly 12% after its report earlier this month, while Molina stock dropped by roughly 8%. Both stocks have remained depressed since. Health Care (XLV) is the worst-performing sector in the S&P 500 this year. Centene stock dropped by roughly 15% in premarket trading after its earnings release before recovering to a positive gain of roughly 6% by the closing bell on Friday. The buoy was led by CEO Sarah London's announcement that Centene was reinstating earnings guidance after pulling this forecast earlier in the month. The company also reported revenue of $48.7 billion, which topped estimates for $44.2 billion, and said it expects to be able to raise the payments it gets from states for Medicaid plans, which would improve its margins. UnitedHealth's MCR challenge The premium-to-cost ratio will be closely watched at UnitedHealth Group (UNH), which refers to this measure as its "medical care ratio" (MCR) and is slated to release Q2 earnings next week. After seeing its medical care ratio rise to 85.1% in the second quarter last year, UnitedHealth is expected to see its ratio jump to 89.3% this year, according to Bloomberg consensus estimates. An increase like that would mean tighter margins and less overhead for a company that already slashed its forecast earlier this year. That news sent its stock price down by 22%, its biggest drop in a single day since 1998. "Management noted care activity trends continue to run ahead of its previous expectations driven by a greater than expected impact at UHC from new members, further acceleration of [Medicare Advantage] utilization and indications of potential broadening trend among adjacent, complex populations," Truist Securities analysts wrote in a May analyst note about UnitedHealth. Closely watched by investors and analysts will also be how UnitedHealth leadership addresses its disclosure Thursday morning that the insurer is facing and complying with a criminal and civil investigation by the Department of Justice over potential fraudulent billing practices in the insurer's Medicare Advantage program. The stock dropped 4.7% through Thursday trading after the disclosure. The probe comes after reporting by the Wall Street Journal earlier this year that documented the potentially fraudulent activity by UnitedHealth, among other medical insurers, which included insurers' staff doctors and nurses adding diagnoses to patients' profiles on top of those documented by the patients' doctors. UnitedHealth may have to answer investor inquiries about the investigation on its earnings call on Tuesday, though these are far from the only challenges facing the insurance giant. According to former federal prosecutor Scott Hogan, the DOJ's Medicare probe will be looking to establish a prolonged pattern of wrongdoing by the insurer. "If everything comes back good for the company, if the department [closes its investigation], I think the company will be able to reassure the marketplace," Hogan, who specialized in fraud investigations, told Yahoo Finance on Friday. Even if UnitedHealth is eventually cleared of wrongdoing, he said, "If the investigation takes next steps, whether it's a lawsuit or prolonged investigation, I don't think there are many companies that desire those kinds of headlines." Jake Conley is a breaking news reporter covering US equities for Yahoo Finance. Follow him on X at @byjakeconley or email him at Click here for in-depth analysis of the latest stock market news and events moving stock prices Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Tesla Shares Tumble. Is It Time to Buy the Dip or Run for the Hills?
Tesla Shares Tumble. Is It Time to Buy the Dip or Run for the Hills?

Yahoo

time9 minutes ago

  • Yahoo

Tesla Shares Tumble. Is It Time to Buy the Dip or Run for the Hills?

Key Points For a second straight quarter, Tesla posted weak auto deliveries and revenue. The company once again hyped its robotaxi and robot ambitions. The stock is largely valued based on future bets paying off, making it risky to own. These 10 stocks could mint the next wave of millionaires › Tesla (NASDAQ: TSLA) has long been a stock that's traded more on the vision of its founder Elon Musk than on its actual fundamentals. However, with the stock sinking following Tesla's lackluster second-quarter earnings report -- despite more big promises around robotaxis and robots -- reality might finally be catching up to it. Musk has done a lot of brand damage to Tesla over the past six months or so. His funding of President Donald Trump's campaign and overseeing the Department of Government Efficiency (DOGE) angered many liberal-leaning consumers. He then later got in a very public feud with the President he helped get elected, alienating himself and Tesla from many conservatives, as well. The fallout could be seen in Tesla's Q2 numbers, while tariffs also stung the company. Meanwhile, it will soon see an even potentially bigger headwind due to the expiration of the U.S. electric vehicle (EV) credit by the end of third-quarter 2025. Its core auto business is struggling For the second straight quarter, Tesla saw big declines in its core auto business. After a 13% drop in deliveries in the first quarter, deliveries fell by the same amount in Q2. Model 3 and Model Y deliveries decreased by 12%, while other models plunged by 52%. Tesla's auto revenue plunged 16% to $16.7 billion in the quarter. Within its auto revenue, its regulatory credits, which are pure gross margin, fell by more than half to $429 million. Not surprisingly, this affected Tesla's profitability in the quarter. Even worse for the company is that many of these regulatory credits will soon be going away. Trump's "Big Beautiful Bill" will eliminate the current federal $7,500 EV tax credit at the end of September. As a result, Musk admitted that the company could be in for a "few rough quarters" ahead. Overall, Tesla's revenue fell 12% to $22.5 billion. Its energy generation and storage revenue dropped 7% to $2.8 billion, while its service revenue climbed 17% to nearly $3.1 billion. Adjusted earnings per share sank 23% to $0.40, while its adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) declined by 7% to $3.4 billion. Tesla's cash flow is also starting to take a hit. Its operating cash flow sank 30% to $2.5 billion, while its free cash flow cratered by 89% to $146 million. More big promises Given Tesla's poor operating results, it was not surprising that Musk and the rest of management directed the conversation toward Tesla's big bets on autonomous driving and robotics. Musk claimed that Tesla will expand its autonomous ride-hailing service to cover half of the U.S. population by the end of this year, pending regulatory approval. Now, of course, such a statement makes little sense. The company is currently only testing a small geofenced area in Austin, Texas, with safety drivers, and it has already had a number of safety issues in this small pilot. Its technology appears nowhere close to ready to be adopted in cities countrywide. But let's say, for argument's sake, that the technology and regulatory approvals work out. The company would then need hundreds of thousands of Level 4 autonomous driving vehicles on the road (not its current Level 2 vehicles). Beyond that, it would also need service and cleaning centers, as well as charging infrastructure in place to handle a fleet of that size. It would also need to have a consumer-facing platform that can handle things like pre-trip pricing, dynamic fare calculations, disputes, and refunds. There is no evidence that Tesla has any of this in place. Meanwhile, Musk continued to sing the praises of his Optimus robot, saying it will be Tesla's biggest product ever. He said Optimus 3 has an "exquisite" design with no significant flaws. He's looking to have a prototype of the new robot by the end of this year and then scale production next year. He then wants to be able to produce 1 million Optimus robots a year within five years. Once again, this seems ambitious. Amazon (NASDAQ: AMZN) is currently an AI robotics leader, and companies like Boston Dynamics have showcased robots with advanced mobility, so robots can be hugely useful. However, all Tesla has ever demonstrated is a humanoid robot that could only do carefully choreographed tasks. Today, most factory automation is done by specialized, fixed-purpose robots. The use case for a humanoid robot is still very questionable. Should investors buy the dip? Even after the stock pullback, Tesla's stock trades at a forward price-to-earnings ratio (P/E) of over 170x based on 2025 analyst estimates, while its profitable auto peers -- like Ford, General Motors, and Stellantis -- generally have multiples of 10 or less. With its core auto business struggling, this indicates that the bulk of Tesla's market cap is predicated on ambitions that may or may not pan out. Given the company's track record of overpromising and under-delivering, this is not a bet I'd make. Should you buy stock in Tesla right now? The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $636,628!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,063,471!* Now, it's worth noting Stock Advisor's total average return is 1,041% — a market-crushing outperformance compared to 183% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 21, 2025 Geoffrey Seiler has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Amazon and Tesla. The Motley Fool recommends General Motors and Stellantis. The Motley Fool has a disclosure policy. Tesla Shares Tumble. Is It Time to Buy the Dip or Run for the Hills? was originally published by The Motley Fool Sign in to access your portfolio

More than 80% of Americans drink caffeine. These people tried to quit.
More than 80% of Americans drink caffeine. These people tried to quit.

Yahoo

time9 minutes ago

  • Yahoo

More than 80% of Americans drink caffeine. These people tried to quit.

Giving up caffeine isn't easy. Brigette Muller wasn't a big fan of caffeine for most of her life. Just a few sips just made her jittery and never seemed to have any upsides. But, during the COVID-19 pandemic, Muller started drinking Olipop's 'healthy soda,' she tells Yahoo. She especially loved the Vintage Cola flavor with prebiotics. 'I became addicted to Olipop, and I loved it, and I was like, 'I feel so good and energized!'' On a whim, Muller checked the ingredients and found a surprising explanation for her love of the soda: 50 milligrams of caffeine. 'I accidentally started drinking caffeine," she says. By then, Muller was drinking about three cans a day. Though consuming up to 400 milligrams of caffeine a day is considered safe, and Muller still thinks of Olipop as 'healthy' soda, she figured 150 milligrams of caffeine was probably more than she should be drinking. So she tried to cut back. But giving up Olipop just 'got me deeper into coffee,' she says. Iced lattes and teas took the soda's place in her routine. Then, one day this year, Muller got what she calls 'an intuitive hit,' which told her 'caffeine is keeping you in fight-or-flight,' she says. After going down to one kombucha (typically around 15 milligrams of caffeine per 8-ounce serving) a day, Muller got off caffeine entirely and says she realized 'how it truly feels to be calm.' Still, after three weeks of zero caffeine, she's back to allowing herself an occasional Olipop or other soda — never more than one a day. She insists that 'this time is different' and that she won't slip back into her old caffeine habits. It's hard to give up caffeine — though many people try. According to a June 2025 Yahoo/YouGov poll of nearly 1,600 U.S. adults, 81% of Americans drink caffeine. And of that large majority, 30% have tried to give it up. But when we asked readers if they had ever given up caffeine successfully, only 6% of regular caffeine drinkers said, "yes." So, just what happens when you do, and why do we keep coming back for more? Here's what we learned from people who've tried to quit caffeine and experts who know all too well how the buzzy ingredient works. Dunkin' or otherwise, much of America runs on caffeine Only 19% of people we surveyed said they don't drink caffeine. And among the 81% who do, many aren't having just one morning cup of joe. While 32% said they have caffeine once daily, nearly as many (29%) reported reaching for a caffeinated beverage several times a day. Grocery stores and gas stations are stocked with countless caffeinated options, but coffee is still king. Nearly half (48%) of survey respondents who consume caffeine said that coffee is their primary source, compared to 20% who are mainly soda drinkers. Tea generally has a lower concentration of caffeine than coffee and is the go-to for just 7% of caffeine drinkers, according to our survey. A few people cite energy drinks as their main caffeine source, with 4% consuming beverages like Monster, Red Bull and Celsius. Some of these drinks are promoted as better-for-you beverages because they contain zero sugar or are free from artificial flavors and high-fructose corn syrup. That convinced 32-year-old Adorian Deck to give Celsius a try. The content creator thought it was 'healthier the way it was marketed,' he tells Yahoo. 'It tastes great and gets at my craving for soda because it's basically just a sugar-free soda, but it's ultimately the same trap I fell into with Diet Coke.' In reality, energy drinks are often high in caffeine. Celsius drinks, in particular, contain between 200 and 300 milligrams of caffeine per can. While one energy drink is unlikely to cause severe health consequences, more than 30 deaths in the U.S. have been linked to various energy drinks, including Red Bull, Monster and the alcoholic energy beverage Four Loko. Is caffeine good or bad for you? Like many things, caffeine is fine in moderation. Some research even suggests that people who drink some caffeine, especially from coffee, tend to be in better health than those who either don't consume it or drink a lot of it. Coffee's antioxidants may also offer protective effects against conditions including heart disease, diabetes and cancer. But, because it's a stimulant, caffeine can also cause 'the body to go into a stress response,' raising the heart rate and blood pressure and leading to jitteriness and the feeling of an energy crash once its effects wear off, Lina Begdache, a Binghamton University nutritional neuroscientist, tells Yahoo. Some people are especially sensitive to those effects, while others hardly notice them, she adds. Jordan Tarver, an American writer living in Spain, found out firsthand that he's someone who's very sensitive to caffeine. His wife gave up caffeine while addressing some health issues, but she never was particularly affected by it, Tarver says. 'That was so interesting to me, because I have one sip of coffee and I'm like, buzzing,' he tells Yahoo. Tarver first realized that his two to three cups of coffee a day might be the reason he felt jittery and anxious. 'On a day when I had nothing to do, drinking coffee made me feel like I had a thousand things on my plate,' he says. He cut back and tried to substitute in matcha. But 'the jitteriness and anxiousness were still blocking my creative channel and keeping me from the calm space you need to be in to make art,' he says. Tarver finally went cold turkey in September 2024 and hasn't looked back. 'I love to just not be dependent on things,' he says. But, Tarver admits, 'I miss that routine, and I'm still a coffee lover — we just don't have the greatest relationship.' What makes caffeine so hard to quit? After developing a dependence on energy drinks, as well as coffee and soda, Deck finally gave up caffeine cold turkey during the COVID-19 pandemic. It took him nearly a month to stop having withdrawal symptoms like headaches and fatigue. But, ultimately, he loved getting off caffeine and discovered that he had more consistent energy throughout the day (though, since becoming a new dad last year, he does allow himself an occasional morning cup of coffee). He eventually took to TikTok to make a video about his experience, not to try to evangelize against coffee, soda or energy drinks, but because 'a lot of people don't know what caffeine really is, how it affects your body and that it's a normalized drug,' he says. While these beverages aren't classified as drugs by the U.S. government, biologically speaking, they very much are, explains Begdache. 'Caffeine is a brain stimulant, meaning it makes the brain more focused and energized,' she says. But it also has 'addictive properties and dependency properties.' These addictive substances activate the brain's reward systems, so you feel extra good when you have them and bad when those substances are taken away. Withdrawals happen when you become dependent on a substance, meaning you won't feel like you're functioning normally if you don't have it. How addicted and dependent you become on caffeine depends on your pattern of use (one cup of coffee vs. three or four with sodas or energy drinks in between, for example) and your genetics, says Begdache. But, in general, people who regularly consume caffeine can become dependent on it in a matter of weeks. The good news is that 'you can be on caffeine for years and reverse the addiction within a very short period,' says Begdache. The worst of caffeine withdrawals — marked by headaches, irritability, fatigue and trouble focusing — are usually over within about nine days. The benefits of quitting caffeine — and how to do it successfully Allie Williams, a 33-year-old pediatric occupational therapist, knows a thing or two about quitting. She quit drinking alcohol at the end of 2024. She'd never been a heavy drinker, but her social drinking started catching up with her in her 30s, so Williams decided "it wasn't a good look for me,' she tells Yahoo. 'When you quit an addictive habit, you have to face everything underneath it.' Williams had reached for alcohol to provide a sense of excitement in her life. Caffeine, she realized, was another thing she was reaching for 'so I didn't have to ride a low' in her mood or energy, she explains. Her experience quitting alcohol helped Williams get through her caffeine withdrawals, and vice versa. 'They were hard in different ways. Caffeine was harder in that I drank it and depended on it every day,' while giving up alcohol changed her social life more, she says. Williams started by switching from multiple iced coffees a day to matcha for six months before giving up caffeine altogether in January. She also knew the change might impact her energy and mood, so she came prepared: 'I had to go through a hermit mode where I didn't do anything,' says Williams, who allowed herself to just eat and sleep more and work out less during that time. If caffeine makes you jittery or you're using it to muscle your way through tiredness, Begdache says it might be time to assess your intake. She says that tapering off like Williams did is the best way to quit without experiencing withdrawal intense enough to derail your efforts. Her other advice: 'It sounds counterintuitive, but if you're quitting caffeine, be more active, because your brain feels the fatigue when you stop drinking caffeine,' says Begdache. 'Exercise helps your brain feel more energized by increasing blood flow.' Once Williams kicked her caffeine habit, she was amazed at how much better she felt. 'I feel so much more balanced. I'm not so up and down, reaching for something to make me feel OK,' she says. Quitting caffeine, she says, 'can totally change your life.' She's sleeping better, her skin has improved and she has plenty of energy, spread evenly throughout her day. 'As a kid, I had so much energy, and I was excited about everything,' she says. 'As I got older, I thought I had to have alcohol and go out to feel excited or have coffee to be energetic, but I still had the energy — it was just covered up by other things,' Williams says. Solve the daily Crossword

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store